Related references
Note: Only part of the references are listed.Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang et al.
NATURE (2012)
Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice
Mingkui Zhou et al.
VACCINE (2012)
Structure-guided Alterations of the gp41-directed HIV-1 Broadly Neutralizing Antibody 2F5 Reveal New Properties Regarding its Neutralizing Function
Javier Guenaga et al.
PLOS PATHOGENS (2012)
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
Morgane Bomsel et al.
IMMUNITY (2011)
Nonneutralizing HIV-1 gp41 Envelope Cluster II Human Monoclonal Antibodies Show Polyreactivity for Binding to Phospholipids and Protein Autoantigens
S. Moses Dennison et al.
JOURNAL OF VIROLOGY (2011)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization
Mikyung Kim et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
HIV-1 gp41 Core with Exposed Membrane-Proximal External Region Inducing Broad HIV-1 Neutralizing Antibodies
Ji Wang et al.
PLOS ONE (2011)
Induction of HIV Neutralizing Antibodies against the MPER of the HIV Envelope Protein by HA/gp41 Chimeric Protein-Based DNA and VLP Vaccines
Ling Ye et al.
PLOS ONE (2011)
Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41
S. Moses Dennison et al.
PLOS ONE (2011)
Rational Design of Vaccines to Elicit Broadly Neutralizing Antibodies to HIV-1
Peter D. Kwong et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
M. Juliana McElrath et al.
IMMUNITY (2010)
Antigenic Characteristics of Rhinovirus Chimeras Designed in silico for En5hanced Presentation of HIV-1 gp41 Epitopes
Mauro Lapelosa et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L
Ann J. Hessell et al.
JOURNAL OF VIROLOGY (2010)
Relationship between Antibody 2F5 Neutralization of HIV-1 and Hydrophobicity of Its Heavy Chain Third Complementarity-Determining Region
Gilad Ofek et al.
JOURNAL OF VIROLOGY (2010)
Ablation of the Complementarity-Determining Region H3 Apex of the Anti-HIV-1 Broadly Neutralizing Antibody 2F5 Abrogates Neutralizing Capacity without Affecting Core Epitope Binding
Jean-Philippe Julien et al.
JOURNAL OF VIROLOGY (2010)
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
Hugo Mouquet et al.
NATURE (2010)
Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies
Gary Frey et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Crystal Structure of HIV-1 gp41 Including Both Fusion Peptide and Membrane Proximal External Regions
Victor Buzon et al.
PLOS PATHOGENS (2010)
Mucosal Immunity and Protection Against HIV/SIV Infection: Strategies and Challenges for Vaccine Design
Thorsten Demberg et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2009)
In Silico Vaccine Design Based on Molecular Simulations of Rhinovirus Chimeras Presenting HIV-1 gp41 Epitopes
Mauro Lapelosa et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope
Gail Ferstandig Arnold et al.
JOURNAL OF VIROLOGY (2009)
A Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies
Robert Pejchal et al.
JOURNAL OF VIROLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
Likai Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Role of HIV membrane in neutralization by two broadly neutralizing antibodies
S. Munir Alam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
Ann J. Hessell et al.
PLOS PATHOGENS (2009)
Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope
Susan W. Barnetta et al.
AIDS (2008)
HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane
Zhen-Yu J. Sun et al.
IMMUNITY (2008)
The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5
Nerea Huarte et al.
JOURNAL OF VIROLOGY (2008)
Challenges in the development of an HIV-1 vaccine
Dan H. Barouch
NATURE (2008)
The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: Dominant site of antibody neutralization and target for vaccine design
Marinieve Montero et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2008)
A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies
Gary Frey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
In vivo efficacy of human immunodeficiency virus neutralizing antibodies:: Estimates for protective titers
Alexandra Trkola et al.
JOURNAL OF VIROLOGY (2008)
Developing a neonatal HIV vaccine: insights from macaque models of pediatric HIV/AIDS
Marta L. Marthas et al.
CURRENT OPINION IN HIV AND AIDS (2007)
Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion
Anna K. Bellamy-Mclntyre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Current concepts: An HIV vaccine - Evolving concepts
Margaret I. Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination
David C. Montefiori et al.
CURRENT OPINION IN HIV AND AIDS (2007)
An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10
Josh D. Nelson et al.
JOURNAL OF VIROLOGY (2007)
Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10
Rosa M. F. Cardoso et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy
Mansun Law et al.
JOURNAL OF VIROLOGY (2007)
Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype
Ranajit Pal et al.
VIROLOGY (2006)
Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody
FM Brunel et al.
JOURNAL OF VIROLOGY (2006)
The 2F5 epitope is helical in the HIV-1 entry inhibitor T-20
Z Biron et al.
BIOCHEMISTRY (2005)
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies
BF Haynes et al.
SCIENCE (2005)
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41
RMF Cardoso et al.
IMMUNITY (2005)
The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5
MB Zwick et al.
JOURNAL OF VIROLOGY (2004)
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
JA Binley et al.
JOURNAL OF VIROLOGY (2004)
Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10
S Mehandru et al.
JOURNAL OF VIROLOGY (2004)
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope
G Ofek et al.
JOURNAL OF VIROLOGY (2004)
Predominant autoantibody production by early human B cell precursors
H Wardemann et al.
SCIENCE (2003)
Structural analysis of the epitope of the Anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion
G Barbato et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions
JM Binley et al.
JOURNAL OF VIROLOGY (2003)
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
DD Richman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structure-affinity relationships in the gp41 ELDKWA epitope for the HIV-1 neutralizing monoclonal antibody 2F5:: effects of side-chain and backbone modifications and conformational constraints
Y Tian et al.
JOURNAL OF PEPTIDE RESEARCH (2002)
Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies
MB Zwick et al.
JOURNAL OF VIROLOGY (2001)
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
PWHI Parren et al.
JOURNAL OF VIROLOGY (2001)
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
JR Mascola et al.
NATURE MEDICINE (2000)
Share Paper
